CEO Daily readers on the potential risks—and rewards—of 2022, from inflation to Net Zero

A drugmaker’s COVID-19 vaccine is 78% effective—but can it escape its spotty corporate history?

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today. On Thursday, Brazilian authorities said private Chinese vaccine maker Sinovac’s COVID-19 candidate was 78% effective in preventing infections, allowing it to join companies like Pfizer, Moderna, and AstraZeneca as leaders in the global race to […]

From Paris Hilton to Gmoney, here’s what the biggest names in NFTs say the future holds

Fortune’s foray into the world of NFTs was a smashing success Friday, with all 256 limited editions of our latest cover selling out instantly. Read More

Johnson & Johnson: The pause heard ’round the world

From Europe to Africa, the U.S. ‘pause’ on the J&J vaccine has had dramatic fallout. Read More